Management's Discussion and Analysis contains various "forward looking statements" within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, regarding future events or the future financial performance of the Company that involve risks and uncertainties. Certain statements included in this Form 10-Q, including, without limitation, statements related to anticipated cash flow sources and uses, and words including but not limited to "anticipates", "believes", "plans", "expects", "future" and similar statements or expressions, identify forward looking statements. Any forward-looking statements herein are subject to certain risks and uncertainties in the Company's business, including but not limited to, reliance on key customers and competition in its markets, market demand, product performance, technological developments, maintenance of relationships with key suppliers, difficulties of hiring or retaining key personnel and any changes in current accounting rules, all of which may be beyond the control of the Company. The Company adopted at management's discretion, the most conservative recognition of revenue based on the most astringent guidelines of the SEC in terms of recognition of software licenses and recurring revenue. Management will elect additional changes to revenue recognition to comply with the most conservative SEC recognition on a forward going accrual basis as the model is replicated with other similar markets (i.e. SBDC). The Company's actual results could differ materially from those anticipated in these forward-looking statements as a result of certain factors, including those set forth therein.

Forward-looking statements involve risks, uncertainties and other factors, which may cause our actual results, performance or achievements to be materially different from those expressed or implied by such forward-looking statements. Factors and risks that could affect our results and achievements and cause them to materially differ from those contained in the forward-looking statements include those identified in the section titled "Risk Factors" in the Company's Annual Report on Form 10-K for the year ended December 31, 2008, as well as other factors that we are currently unable to identify or quantify, but that may exist in the future.

In addition, the foregoing factors may affect generally our business, results of operations and financial position. Forward-looking statements speak only as of the date the statement was made. We do not undertake and specifically decline any obligation to update any forward-looking statements.

Overview

Bond Laboratories (the "Company") is a national provider of innovative and proprietary nutritional supplements and beverage products for health conscious consumers. The Company produces and markets its products through its two primary operating divisions - NDS Nutrition and Fusion Premium Beverages. NDS manufactures and distributes a full line of nutritional supplements to support healthy living through a variety of retail channels including GNC franchisee locations located throughout the United States. Fusion Premium Beverages distributes a line of health and energy beverages to support and promote an active lifestyle.

The Company was incorporated in the state of Nevada on July 26, 2005. Fusion Premium Beverages, (formally Got Fusion, Inc.), a wholly owned subsidiary of the Company, was incorporated in August of 2007. In October 2008, the Company acquired the assets of NDS Nutritional Products and moved those assets into a separate wholly owned subsidiary, Nutritional Products, Inc. The Company established a third wholly owned subsidiary Vista Bottlers, Inc. on March 2, 2009 to expand its operations to include private label bottling capabilities. . The Company's operating subsidiaries are led by a team of highly experienced sales and marketing executives with considerable expertise in the development, launch and distribution of branded products in the nutritional supplement and beverage sector. Bond Laboratories is headquartered in Omaha, Nebraska and maintains a sales office in Dallas, TX. For more information on the Company, please go to http://www.bond-labs.com.

Bond Laboratories, Inc. trades under the symbol BNLB on the OTC:BB market.

Fusion Premium Beverages, Inc.

Fusion Premium Beverages is focused on the development, production and distribution of unique and differentiable functional beverages targeted at active and health conscious consumers. Current products include:

? Resurrection™, and
? 6+ Hour Energy Boost

Resurrection™

Management believes that Resurrection™ is the first ever "pretox" Beverage with a proprietary herbal compound that helps eliminate the internal body processes that cause a hangover. Resurrection™ Antihangover drink created a new beverage category for the industry. The Company is a leading innovator in the industry and seeks to leverage its strong market position to drive the rapid adoption of Resurrection™, as well as to facilitate the introduction of new, proprietary functional beverages to the market.

6+ Hour Energy Boost

Fusion has developed an exclusive portfolio of energy products, including our 2oz. 6+ Hour Energy Boost shot, targeted at prevailing consumer trends and needs.

NDS Nutrition, Inc.

NDS Nutrition markets a full line of sports, weight loss and general nutrition products through numerous distribution channels on national basis. Key products include:

? Release Weight Loss,
? Professional Muscular Development, and ? Doctor Health.

Competition

Management anticipates that we will encounter competition in each market that we enter. Patent and trademark applications that cover new embodiments of technology will be pursued whenever possible. While we cannot assure that such measures will block competitive products, we believe our continued emphasis on innovation and new product development targeted at the needs of the consumer will enable the Company to effectively compete in the marketplace.

Results of Operations

Revenues for the three months ended increased to $2,204,650 from $501,290 for September 30, 2009 and 2008 respectively. Revenues for the nine months ended increased to $6,961,317 from $1,126,659 for September 30, 2009 and 2008, respectively. This increase was primarily attributable to the following factors:
i) the acquisition of NDS Nutrition which has been reflected in our financial statements since October 1, 2008; ii) the launch and continued rapid adoption of Resurrection, Fusion Premium Beverages newest functional beverage; and iii) aggressive growth across all of the Company's primary operating divisions.

Cost of goods sold for the three months ended increased to $1,829,187 from $294,866 for September 30, 2009 and 2008, respectively. Cost of goods sold for the nine months ended increased to $5,225,967 from $598,803 for September 30, 2009 and 2008 respectively. Our cost of goods sold is directly related to the increase in our sales. The Company incurred several non-recurring expenses during the three months ended September 30, 2009, which reduced gross margin to approximately 17%. Adjusting for such charges, gross profit and gross margin for the three months ended September 30, 2009 increased to $521,254 from $375,463, respectively and 26.3% from 17.0%, respectively.

General and administrative expense for the three months increased to $5,652,198 from $298,267 for September 30, 2009 and 2008, respectively. General and administrative expense for the nine months increased to $7,441,315 from $1,622,730 for September 30, 2009 and 2008 respectively. General and administrative expense for the three and nine months ended September 30, 2009, included $4,254,594 and $4,537,190, respectively, of non-cash, non-recurring expenses related to the issuance of warrants in connection with certain private placement transactions completed during the quarter. The Company elects to expense all such non-cash, non-recurring expenses in the quarter incurred. Absent the non-recurring expenses related to the issuance of warrants, General and administrative expense would have been $1,397,604 and $2,904,125 for the three and nine months ended September 30, 2009, respectively, which included $368,322 and 4,953 of non-cash expenses, respectively.

Selling and marketing expense for the three months decreased to $150,591 from $890,485 for September 30, 2009 and 2008, respectively. Selling and marketing expense for the nine months decreased to $528,424 from $2,523,322 for September 30, 2009 and 2008, respectively.

Depreciation and amortization for the three months increased to $70,155 from $4,953 for September 30, 2009 and 2008, respectively. Depreciation and amortization for the nine months increased to $208,869 from $16,602 for September 30, 2009 and 2008, respectively. The increase in depreciation and amortization relates to the acquisition of new assets from NDS Nutrition Products, Inc. in the fourth quarter of 2008.

Net loss for the three months increased to $5,536,657 from $955,416 for the three months ended September 30, 2009 and 2008, respectively. Net loss for the nine months ended increased to $6,437,378 from $3,709,622 for September 30, 2009 and 2008, respectively. A substantial portion of the net loss for the three and nine months ended September 30, 2009 were non-cash, and believed by management to be non-recurring. Non-cash, non-recurring expenses related to the issuance of warrants was $4,254,594 for the three months ended September 30, 2009 and $4,537,190 for the nine months ended September 30, 2009. Non-recurring and/or non-cash expenses are evidenced in the below table.

                                            Three Months       Nine Months
                                                Ended             Ended
                                            September 30,     September 30,
Net Loss as adjusted for non-recurring
and/or non-cash expenses                        2009              2008

Losses available for common shareholders    $  (5,536,657 )   $  (6,437,378 )

Non-cash expense related to issuance of
warrants                                        4,254,594         4,537,190
Other non-cash expenses                           368,322           507,035
Stock issued for services                         569,013           591,200

Losses available for common shareholder,
as adjusted                                 $    (345,029 )   $    (731,953 )

Liquidity and Capital Resources

We have maintained a minimum of three months of working capital since September of 2005. This reserve was intended to allow for an adequate amount of time to secure additional funds from investors as needed. To date, management has succeeded in securing capital as needed. During the nine months ended September 30, 2009, we sold 10,683,625 shares of common stock and shares of Series B Preferred Stock for an aggregate gross proceeds to the Company of $2,746,375.

Our cash provided (used) in operating activities is $373,983 and ($2,345,697) for the nine months ended September 30, 2009 and 2008, respectively. The decrease is mainly attributable to the decrease in operating expenses including inventory buildup during the prior year.

Cash used by investing activities was ($34,995) and ($1,719) for the nine months ended September 30, 2009 and 2008, respectively.

Cash provided by financing activities was $3,689,375 and $3,247,287 for the nine months ended September 30, 2009 and 2008, respectively. We received proceeds from an affiliate of $49,321, and repaid our notes payables of $362,856 during the nine months ended September 30, 2009. We received proceeds from notes payables of $268,457 and issued common shares and paid cash for the cost of raising capital of $616,066.

You are advised to read this Form 10-Q in conjunction with other reports and documents that we file from time to time with the SEC. In particular, please read our Quarterly Reports on Form 10-Q, Annual report on Form 10-K, and Current Reports on Form 8-K that we file from time to time. You may obtain copies of these reports directly from us or from the SEC at the SEC's Public Reference Room at 100 F. Street, N.E. Washington, D.C. 20549, and you may obtain information about obtaining access to the Reference Room by calling the SEC at 1-800-SEC-0330. In addition, the SEC maintains information for electronic filers at its website http://www.sec.gov.